Light therapy is gaining immense popularity for treating a variety of diseases. According to Coherent Market Insights, the global light therapy industry is set to grow at a CAGR of 5.2% during the forecast period. The target industry value will likely cross US$ 1410.9 million by the end of 2030.
Koninklijke Philips N.V., PhotonMD, Inc., Verilux, Inc., BioPhotas, TheraLight LLC, Beurer GmbH, Johnson & Johnson, and Zepter International are few light therapy device manufacturers and suppliers. These players are constantly innovating to develop advanced phototherapy devices.
Top players are initiating new trials to demonstrate the effectiveness of light therapy in treating various diseases. Acquisitions, partnerships, and collaborations are also becoming common in the industry.
In June 2024, TheraLight LLC, a global leader in light therapy, launched TheraLight 360+ full body photobiomodulation therapy bed. The new bed brings additional power to the combined wavelengths of 810nm, 633nm, 850nm, and 940nm.
TheraLight 360+ has 25% more power. It features a more robust shell casing and enhanced tablet control and is designed to improve the patient experience and provide better therapeutic outcomes.
In August 2024, TheraLight also received a new patent for its photobiomodulation system from USPTO. This is set to introduce groundbreaking advancements in light therapy technology.
In March 2025, PhotoPharmics, a leader in specialized phototherapy for neurodegenerative diseases, started latest phototherapy trial for Parkinson’s disease. The new trial is intended to assess the efficacy of the company’s breakthrough phototherapy device, Celeste to improve overall function and quality of life in Parkinson’s disease.
Key Factors Propelling Light Therapy Industry Growth
The global light therapy industry is set to witness steady growth. This is due to growing usage of light therapy for managing and treating a wide range of diseases.
Light therapy is becoming a popular solution for treating different skin conditions and mental disorders. This is mainly due to its higher effectiveness, less side effects, and non-invasive nature.
More and more people are opting for light therapy to address skin conditions like acne and eczema. It also helps them to reduce wrinkles and improve overall skin health. Phototherapy for treating skin conditions is becoming trendy, leading to its higher demand.
Global prevalence of mental health disorders is acting as a catalyst triggering growth of the phototherapy industry. People with SAD, depression, and mood disorders are giving preference to light therapy over antidepressants. This is leading to a higher demand for light therapy.
Development of new phototherapy devices is also impacting the industry’s growth. Leading players are constantly launching novel light therapy devices with improved features. They are also receiving support from the regulatory bodies. For instance, in 2024, LumiThera Inc. received USFDA approval for marketing of Valeda Light Delivery System for treatment of patients with dry age-related macular degeneration.
Regional Insights
North America remains at the top of the ladder in the light therapy industry. This is due to growing demand for non-invasive treatments for treating mental and skin conditions. Similarly, strong presence of leading light therapy device manufacturers and favourable government support are fostering growth in the region.
